DPDavy Henrique Sousa Pelliciari

Davy Henrique Sousa Pelliciari

*This is an algorithmically generated author record based on publicly available information.

Davy Henrique Sousa Pelliciari has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • TAC-Tic syndromes: a case series on the complex overlap between trigeminal autonomic cephalalgias and trigeminal neuralgia

    by de Sousa Pelliciari, Davy Henrique, Larissa Aguiar Garcia, Carlos Alberto Bordini, Jaqueline Silva Ribeiro

  • Open Access

    Primary stabbing headache – a narrative review

    by Davy Henrique de Sousa Pelliciari, Gabriela Pinheiro Silva, Gabriela e Silva Pires, Carlos Alberto Bordini

    IntroductionPrimary stabbing headache (PSH), also known as “ice-pick headache”, is characterized by sudden, ultrashort stabs of head pain and may be under-recognized due to overlap with other headache disorders and mimics.ObjectiveTo provide a narrative overview of PSH, summarizing epidemiology, proposed mechanisms, clinical features, differential diagnosis, taxonomic evolution across ICHD editions, and reported treatments.MethodologyA targeted search in PubMed/MEDLINE, SciELO and LILACS was complemented by manual reference screening, including key references cited in ICHD-3 (section 4.7). Keywords related to PSH were combined with “clinical presentation”, “epidemiology”, “diagnostic criteria” and “treatment”. Articles in English, Portuguese or Spanish were considered.ResultsFrequency estimates vary by definition and setting. Pediatric sources generally describe PSH as an uncommon diagnosis among children with recurrent headaches, with onset often during school-age years. In adults, estimates range from low values in population studies using stricter definitions to higher rates in community surveys eliciting ultrashort stabbing “jabs”. Attacks last seconds and occur as single jabs or brief series, with variable topography and laterality. Associated symptoms may reflect comorbidity (especially migraine); prominent cranial autonomic features should prompt reassessment for trigeminal autonomic cephalalgias or secondary causes when red flags are present. Evidence for treatment is largely uncontrolled; indomethacin is most frequently reported, while other agents appear in small series.ConclusionPSH is generally benign, but its reported frequency and phenotype are heterogeneous across studies. ICHD-3 broadened diagnostic inclusion beyond V1 distribution, potentially improving clinical fit. Careful differential diagnosis remains essential in atypical presentations.

  • Open Access

    DESAFIOS E APRENDIZADOS NO USO DO TESTE DE SNELLEN EM CRIANÇAS: UM RELATO DE EXPERIÊNCIA

    by Davy Henrique De Sousa Pelliciari, Manuela Da Cruz, Maria Eduarda Spirlandelli, Mariana Fröner Steck, Patrícia Costa da Silva, Rafael Teles Augusto, Raquel Rangel Cesario

    Objective: To describe the experience and its impact on the construction of knowledge of third-semester medical students. Data synthesis: An intervention was carried out in a school on the outskirts of a city in the interior of the state of São Paulo, where medical students applied the Snellen test so that the visual status of children could be analyzed. During the application of the test, it was possible to have a greater understanding of the theoretical content learned in the classroom, and its application in practical cases in society, strengthening the skills and techniques essential for the training of future health professionals. Conclusion: The practical activity made it possible to observe the limitations present in the scale used in front of a student with cognitive impairment and to analyze the need for other interventions that discuss issues known during the application of the test, in addition to bringing together theoretical and practical content, necessary pieces for the training of a good professional.

  • Open Access

    Boundaries of visual phenomena in migraine: the charles bonnet’s syndrome - report of two cases

    by Davy Henrique Sousa Pelliciari, Carlos Alberto Bordini

    IntroductionTwo patients were referred to a tertiary headache center due to complex visual phenomena that might be related to migraine aura. Eventually, it turned out that they were Charles Bonnet syndrome (CBS) patients. The syndrome is characterized by vivid visual hallucinations in the absence of other psychiatric symptoms, often in patients with optical morphophysiological disorders. The pathophysiology of CBS remains uncertain, and the syndrome lacks robust diagnostic criteria. So far, reports on CBS are scarce in Brazilian neurological literature, leading to challenges in identification and diagnosis. The condition is primarily recognized through anamnesis and clinical examination.ObjectiveTo report two cases of CBS to draw the attention of headache specialists about this syndrome.Case reportsThe first case involves a 93-year-old male patient, retired, who reported experiencing vivid hallucinations sometimes of an old white car and sometimes a group of children. Despite the clarity of these visions, the patient remained aware that they were not real. In the second case, a 70-year-old male farmer began experiencing hallucinations involving scratches, scribbles, letters, stones, and women in his visions. ConclusionHere two cases of CBS were reported concerning a not so rare condition, but for sure very uncommon to headache specialists.

  • Open Access

    SHOULD ANTI-CGRP MONOCLONAL ANTIBODIES ALWAYS BE THE DRUG OF FIRST CHOICE FOR MIGRAINE PROPHYLAXIS IN BRAZIL? - A PHARMACOECONOMIC STUDY

    by Davy Henrique Sousa Pelliciari, Caio Ricco Alves Reis, Carlos Alberto Bordini

    Efficacy (success of therapy under ideal conditions), efficiency (the relationship between the costs and outcomes of a specific intervention), and effectiveness (the balance between efficacy and efficiency in clinical practice) are measures used to evaluate health interventions. Thus, in private practice and the public health system, the knowledge of these pharmacoeconomic data should influence the appropriate treatment choice. Migraine prophylaxis falls within this context. Traditional medications are available in the public health system, while galcanezumab is not routinely available. The present study aims to analyze the efficacy and effectiveness of galcanezumab and traditional therapeutic alternatives (amitriptyline, divalproex sodium, and topiramate). Efficacy data were obtained from the relevant literature (PubMed) and cost values from the ABCFARMA magazine. The economic impact analysis considered the cost of living for an economically active adult in Brazil based on the Brazilian Institute of Geography and Statistics (Instituto Brasileiro de Geografia e Estatística, IBGE) and the Institute for Applied Economic Research (Instituto de Pesquisa Econômica Aplicada, IPEA). Efficacy: amitriptyline: 40%; divalproex sodium: 30%; topiramate: 31%; galcanezumab: 50%. Their annual costs were: amitriptyline R$ 240.00; sodium divalproate R$ 876.00; topiramate R$ 600.00; galcanezumab R$ 13,992.00. Efficiency: amitriptyline 200%; divalproex sodium 41.1%; topiramate 62%; galcanezumab 4%. Ultimately, effectiveness is amitriptyline 120%; divalproex sodium 35.7%; topiramate 46.5%; galcanezumab 27%. Galcanezumab is the most effective; however, in a broader analysis, where payers, availability, and patient conditions are considered, evaluating efficacy alone may not be feasible in practical contexts and, therefore, anti-CGRP antibodies will not always be the first-line medications in migraine prophylaxis.